Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy

NCT02049762 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02049762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2017
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, novel p2y12 inhibitors, platelet function and reactivity tests